Search results for: 'global 2014 2024'

This research explores the powerful global forces that will reshape business, society, and technology over the coming decade, offering a holistic view of the megatrends redefining the future operating environment. These forces span geopolitical fragmentation, demographic divergence, technological acceleration, environmental pressures, and fundament...

In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...

19 Feb 2025  |  Global  |  Market Research

Antimicrobial Resistance Diagnostics Market, Global, 2024–2030

The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput

Infographics

×

This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to in...

Femtech is an emerging term and, as is the case with most new concepts, is poorly understood. While some relate Femtech only with products unique to the female anatomy (including consumer products), others dismiss it as just another term for a group of existing solutions. Frost & Sullivan believes it is a unique space and a place for new growth opp...

20 Jan 2025  |  Global  |  Market Research

Global Cardiac Biomarkers Diagnostics Industry, 2024-2029

Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics

Infographics

×

The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...

05 Sep 2019  |  Global  |  Market Research

Digital Transformation of the Global Medtech Industry, Forecast to 2024

Growth Opportunities to Boost Revenue in this Slowing Industry by an Additional $240 Billion by 2024

Infographics

×

Key Issues Addressed

The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7Percentage in 2020 to 5.3Percentage in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies. M...

The global medical devices market is currently witnessing disruption, led primarily by two key factors: increasing digitization of healthcare delivery and the transition of care settings to locations outside the hospital. There is an increased use of digital technology across the healthcare value chain, and companies operating in data analytics, ar...

This Frost Radar benchmarks companies and their solutions that enable the exchange and use of data between healthcare applications. Interoperability improves continuity of care, increases communication and connectivity between different stakeholders (e.g., payors, providers, patients, public health bodies), and reduces inefficiencies. Organizat...

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastructure relies on an extensive supply chain involving ...